mgr Tomasz Lenda

mgr Tomasz Lenda

+48 12 3343709
Stanowisko: Specjalista
pokój 2.13 CEPHARES
CEPHARES: https://www.cephares.pl/

Dokonania naukowe

  • Publikacje

The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N<sup>G</sup>-nitro-l-arginine methyl ester administered alone or jointly with l-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats

Autorzy: Czarnecka, A., Konieczny, J., Lenda, T., Lorenc-Koci, E.

DOI: 10.1016/j.brainres.2015.08.006
Date: 2015-01-01

Decreased behavioral response to intranigrally administered GABA<inf>A</inf> agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: Comparison to the classical neurotoxin 6-OHDA

Autorzy: Konieczny, J., Czarnecka, A., Kamińska, K., Lenda, T., Nowak, P.

DOI: 10.1016/j.bbr.2015.01.043
Date: 2015-01-01

Tetracycline-based system for controlled inducible expression of group III metabotropic glutamate receptors

Autorzy: Chrus̈cicka, B., Burnat, G., Brański, P., Chorobik, P., Lenda, T., Marciniak, M., Pilc, A.

DOI: 10.1177/1087057114559183
Date: 2015-01-01

Salsolinol, an Endogenous Compound Triggers a Two-Phase Opposing Action in the Central Nervous System

Autorzy: Możdżeń, E., Kajta, M., Wąsik, A., Lenda, T., Antkiewicz-Michaluk, L.

DOI: 10.1007/s12640-014-9511-y
Date: 2015-01-01

Concentration-dependent opposite effects of 1-Benzyl-1,2,3,4- tetrahydroisoquinoline on markers of apoptosis: In vitro and ex vivo studies

Autorzy: Wa̧sik, A., Kajta, M., Lenda, T., Antkiewicz-Michaluk, L.

DOI: 10.1007/s12640-013-9436-x
Date: 2014-01-01

Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra

Autorzy: Konieczny, J., Czarnecka, A., Lenda, T., Kamińska, K., Lorenc-Koci, E.

DOI: 10.1016/j.bbr.2013.12.019
Date: 2014-01-01

Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: Implications for Parkinson's disease

Autorzy: Konieczny, J., Jantas, D., Lenda, T., Domin, H., Czarnecka, A., Kuter, K., Śmiałowska, M., Lasoń, W., Lorenc-Koci, E.

DOI: 10.1007/s12640-014-9477-9
Date: 2014-01-01

Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: The effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine

Autorzy: Czarnecka, A., Lenda, T., Domin, H., Konieczny, J., Śmiałowska, M., Lorenc-Koci, E.

DOI: 10.1016/j.brainres.2013.10.011
Date: 2013-01-01

The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to parkinson's disease is critically dependent on cell culture conditions

Autorzy: Jantas, D., Roman, A., Kuśmierczyk, J., Lorenc-Koci, E., Konieczny, J., Lenda, T., Lasoń, W.

DOI: 10.1007/s12640-012-9374-z
Date: 2013-01-01

Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT 1A/5-HT2A/5-HT7 and dopamine D 2/D3 receptors

Autorzy: Zajdel, P., Marciniec, K., Maślankiewicz, A., Grychowska, K., Satała, G., Duszyńska, B., Lenda, T., Siwek, A., Nowak, G., Partyka, A., Wróbel, D., Jastrzȩbska-Wiȩsek, M., Bojarski, A.J., Wesołowska, A., Pawłowski, M.

DOI: 10.1016/j.ejmech.2012.11.042
Date: 2013-01-01

Zobacz także